Zimmer Biomet Holdings (ZBH) Net Income towards Common Stockholders Growth (1y) (2010 - 2026)
Zimmer Biomet Holdings (ZBH) Net Income towards Common Stockholders Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.93 Bn | 193.33 Bn | 7.27 Bn | -47.84% |
| 2 | Stryker | 128.56 Bn | 125.08 Bn | 4.50 Bn | 44.34% |
| 3 | Medtronic | 119.26 Bn | 110.04 Bn | 6.41 Bn | 18.55% |
| 4 | Boston Scientific | 73.35 Bn | 72.81 Bn | 3.85 Bn | 13.80% |
| 5 | Edwards Lifesciences | 52.06 Bn | 47.81 Bn | 1.35 Bn | -27.18% |
| 6 | Dexcom | 34.55 Bn | 32.61 Bn | 830.00 Mn | 38.54% |
| 7 | GE HealthCare Technologies | 34.05 Bn | 31.94 Bn | 2.18 Bn | 14.80% |
| 8 | Koninklijke Philips | 26.39 Bn | 23.07 Bn | 4.55 Bn | 73.85% |
| 9 | Steris | 23.15 Bn | 22.67 Bn | 684.20 Mn | 12.92% |
| 10 | Zimmer Biomet Holdings | 19.31 Bn | 18.90 Bn | 1.54 Bn | 30.12% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 30.12% |
| Mar 31, 2026 | 30.58% |
| Dec 31, 2025 | -50.62% |
| Sep 30, 2025 | -7.22% |
| Jun 30, 2025 | -36.90% |
| Mar 31, 2025 | 5.61% |
| Dec 31, 2024 | -229.78% |
| Sep 30, 2024 | 53.07% |
| Jun 30, 2024 | 15.82% |
| Mar 31, 2024 | -25.74% |
| Mar 31, 2023 | 495.75% |
| Mar 31, 2022 | -1,351.06% |
| Dec 31, 2021 | -107.28% |
| Sep 30, 2021 | -106.75% |
| Jun 30, 2021 | 98.90% |
| Mar 31, 2021 | 100.92% |
| Dec 31, 2020 | 17.89% |
| Sep 30, 2020 | -45.12% |
| Jun 30, 2020 | -257.85% |
| Mar 31, 2020 | -306.78% |